Skip to content

Study of the effect of Metformin,OC pills versus their combination on thyroid and lipid profile in patients with Polycystic ovary syndrome

Study of the effect of Metformin,Estrogen-progesterone pills versus their combination on thyroid profile and lipid profile in patients with Polycystic ovary syndrome attending a Tertiary Care Hospital

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/09/009807
Enrollment
90
Registered
2017-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PCOD

Interventions

None listed

Sponsors

self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All adult patients (18 to 40 years old) who are newly diagnosed with PCOS and have shown no symptomatic benefit after being prescribed lifestyle modification for 3 months. 2. Patients who are willing to give written informed consent. 3. Patients who have not previously diagnosed with a thyroid disorder.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women. 2. Patients with other comorbid conditions 3. Patients who are taking other medications which could interfere with planned biochemical measurements. 4. Patients who have a history of treatment with study medications or any other androgen progestin or estrogen consumption, for any other indications in the past 6 months. 5. Patients who have known hypersensitivity to the study medications

Design outcomes

Primary

MeasureTime frame
Effect of Metformin, Estrogen-progesterone pills versus their combination on thyroid and lipid profile in PCOS patients.Timepoint: 1,3MONTHS

Secondary

MeasureTime frame
(1) Correlation between thyroid profile, lipid profile with age and BMI. (2) Comparison of the effect of Metformin, Estrogen-progesterone pills versus their combination on thyroid profile, lipid profile in PCOS patients. Timepoint: 1,3 MONTHS

Countries

India

Contacts

Public ContactP Usha Rani

NIMS

ushapingali@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026